Explore 3 Stock Ideas & Industry Insights Download Free Report

Earnings

Pediatrix Medical Group (NYSE:MD) Adjusted EPS Rises to USD 0.72, Topping Estimates, on 1.7% Revenue Growth

GAAPNet Incomewas USD 47.0 million versus USD 71.7 million. The adjusted figure adds back amortization, stock based compensation and transformational and restructuring expenses, and removes discrete tax items.

Nitish Kishor | 30 October 2026

Monro, Inc. (NASDAQ:MNRO) Adjusted Loss of USD 0.01 Misses Estimate as Comparable Sales Slip 1.8%

Comparable store sales declined 1.8%, entirely accounting for the sales drop. By month, comparable sales were down 1% in July, down 3% in August and flat in September. Tire category sales fell 4% while tire unitVolumeheld flat.

Nitish Kishor | 30 October 2026

MainStreet Bancshares (NASDAQ:MNSB) Q3 Earnings: EPS of USD 0.43 Misses Estimate as Non-Performing Loans Reach USD 92.0 Million

Net interest income rose to USD 18.8 million from USD 17.1 million a year earlier, and the net interest margin on a tax equivalent basis widened to 3.55% from 3.42%. Nine monthEarnings Per Sharewere USD 1.48 versus USD 1.29.

Nitish Kishor | 30 October 2026

Why Did Altria Group (NYSE:MO) Lift Its 2026 Guidance After a Q3 Revenue Beat?

Reported net earnings attributable to Altria were USD 2.52 billion, up 6.0%, andOperating Incomerose to USD 3.31 billion from USD 3.23 billion.

Nitish Kishor | 30 October 2026

Medical Properties Trust (NYSE:MPT) Q3 EPS of USD 0.34 Swings Past Estimate on USD 158 Million Asset Sale Gain

Normalized funds from operations were USD 63.8 million, or USD 0.11 per share, compared with USD 77.2 million, or USD 0.13 per share, a year earlier. Chairman, President and Chief Executive Officer Edward K. Aldag, Jr. described the quarter as evidence of decisive steps …

Nitish Kishor | 30 October 2026

Merck (NYSE:MRK) Q3 Earnings: Keytruda Reaches USD 8.6 Billion as Non GAAP EPS Tops Estimates

Chairman and Chief Executive Officer Robert Davis said the science-led strategy is transforming the business, pointing to oncology data presented at the ESMO congress for the antibody-drug conjugate sac-TMT and a first Phase 3 validation of a therapeutic cancer vaccine.

Nitish Kishor | 30 October 2026

Why Did Myers Industries, Inc. (NYSE:MYE) Post a Net Loss Despite 8.1% Sales Growth in Q3?

Sales growth came from higherVolumeof USD 8.9 million and higher pricing of USD 4.2 million, partly offset by USD 0.2 million of unfavorable currency translation.Operating Incomefrom continuing operations fell 11.2% to USD 14.8 million, and income from continuing operations was USD 4.7 million against …

Nitish Kishor | 30 October 2026

Norwegian Cruise Line Holdings (NYSE:NCLH) Q3 Earnings: Adjusted EPS of USD 1.12 Tops Estimate, Guidance Raised

NetYieldfell 6.5% as reported and 6.7% in constant currency, about 220 basis points better than the 8.9% decline the company had guided to. Chairperson and Chief Executive Officer John Chidsey attributed the result to stronger close-in demand from consumers who deferred summer trips, plus …

Nitish Kishor | 30 October 2026

NextDecade (NASDAQ:NEXT) Swings to USD 0.54 Diluted EPS Versus Estimated Loss as Swap Gains Lift Results

Total net income of USD 573.8 million, before USD 418.5 million attributed to non-controlling interests, reflected a derivative gain of USD 851.2 million versus a USD 74.1 million loss a year earlier. The company attributed the swing to higher forward SOFR rates, which raised …

Nitish Kishor | 30 October 2026

What Investors Are Watching at Newmark Group (NASDAQ:NMRK) After Record Q3 Revenue and a Revised 2026 Outlook

Management Services, Servicing Fees, and Other revenue rose 18.3% to USD 376.3 million, the fifth consecutive record quarter for those businesses, and the servicing and asset management portfolio grew 23.2%. Leasing and Other Commissions gained 26.5%, the best third quarter on record, led byDemandtied …

Nitish Kishor | 30 October 2026
Support

Hi! How can we help you today?

Loading…